{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': 'Bynet Building',
 'address2': '3rd Floor 19 Hartum Street Har Hotzvim',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 6.34,
 'askSize': 2200,
 'averageDailyVolume10Day': 14612,
 'averageVolume': 6142,
 'averageVolume10days': 14612,
 'beta': 0.633179,
 'beta3Year': None,
 'bid': 6.05,
 'bidSize': 1200,
 'bookValue': 1.838,
 'category': None,
 'circulatingSupply': None,
 'city': 'Jerusalem',
 'companyOfficers': [],
 'country': 'Israel',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 6.42,
 'dayLow': 6.01,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -7.109,
 'enterpriseToRevenue': 2.502,
 'enterpriseValue': 55239332,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '972 2 5812517',
 'fiftyDayAverage': 6.255514,
 'fiftyTwoWeekHigh': 12.53,
 'fiftyTwoWeekLow': 5.1,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 3654027,
 'forwardEps': -0.32,
 'forwardPE': -19.687502,
 'fromCurrency': None,
 'fullTimeEmployees': 107,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.02786,
 'heldPercentInstitutions': 0.12505001,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/brainsway.com',
 'longBusinessSummary': 'Brainsway Ltd., a commercial stage medical device '
                        'company, focuses on the development and sale of '
                        'non-invasive neuromodulation products in Israel and '
                        'internationally. It offers deep transcranial magnetic '
                        'stimulation technology for the treatment of major '
                        'depressive disorders, obsessive-compulsive disorders, '
                        'bipolar disorders, post traumatic stress disorders, '
                        "schizophrenia, smoking cessation, Alzheimer's "
                        'disease, Asperger syndromes, alcohol addictions, '
                        'attention deficit hyperactivity disorders, '
                        "Parkinson's disease, and chronic neuropathic pains to "
                        'transmit electric current flows at varying rates and '
                        'creating an electromagnetic field that serves to '
                        'depolarize cortical neurons and activate neural '
                        'networks in various areas of the brain. The company '
                        'primarily serves doctors, hospitals, and medical '
                        'centers in the field of psychiatry. Brainsway Ltd. '
                        'was founded in 2003 and is headquartered in '
                        'Jerusalem, Israel.',
 'longName': 'Brainsway Ltd.',
 'market': 'us_market',
 'marketCap': 69912360,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_34280817',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -11863000,
 'nextFiscalYearEnd': 1640908800,
 'open': 6.42,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '972 2 5813140',
 'previousClose': 6.36,
 'priceHint': 2,
 'priceToBook': 3.4276388,
 'priceToSalesTrailing12Months': 3.1668944,
 'profitMargins': -0.53736997,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 6.42,
 'regularMarketDayLow': 6.01,
 'regularMarketOpen': 6.42,
 'regularMarketPreviousClose': 6.36,
 'regularMarketPrice': 6.42,
 'regularMarketVolume': 3804,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 11125300,
 'sharesPercentSharesOut': 0.001,
 'sharesShort': 4452,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 47,
 'shortName': 'Brainsway Ltd.',
 'shortPercentOfFloat': None,
 'shortRatio': 1.79,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'BWAY',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.082,
 'twoHundredDayAverage': 8.395374,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '4b7576e5-11f7-3ea0-a827-d2fc22b2b272',
 'volume': 3804,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.brainsway.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '9777518'}